GILEAD SCIENCES, INC. for GILEAD SCIENCES INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
International Trade and protection of intellectual property; HIV Testing Issues, HCV issues. Guidance and strategic counsel with regard to pending healthcare legislation and the potential impact on the biopharmaceutical industry; Ryan White Act reauthorization; Hepatitis C policy; PEPFAR reauthorization.Domestic HIV Policy Issues, Hepatitis B Funding for Screening and Linkage to Care Programs, Budget Control Act of 2011 (P.L. 112-25); S. 1284, FY 2014 Labor, HHS and Education Appropriations, Hepatitis Funding for Screening and Linkage to Care Programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH GROGAN | — |
Copyright/Patent/Trademark CPT
HIV/AIDS testing and treatment, technology transfer and patent rights and funding Patient Protection and Affordable Care Act implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH GROGAN | — |
Veterans VET
Education on hepatitis C issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH GROGAN | — |
Medicare/Medicaid MMM
Medicare and Medicaid coverage, access and reimbursement issues for Hepatitis C and HIV.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH GROGAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.